|
MechanismProteasome inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Inhiprot LLC
0 Patents (Medical) associated with Inhiprot LLC
100 Deals associated with Inhiprot LLC
100 Translational Medicine associated with Inhiprot LLC